Brain perfusion abnormalities in rett syndrome: A qualitative and quantitative spet study with 99Tcm-ecd

Nuclear Medicine Communications

Volumn 18, Issue 6, 1997, Pages 527-534

  Burroni, L ^a   Aucone, A M ^a   Volterrani, D ^a   Bertelli, P ^a   Hayek, Y ^a   Vella, A ^a   Zappella, M ^a   Vattimo, A ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

ADOLESCENT; ADULT; ARTICLE; BRAIN PERFUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; RETT SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS;

EID: 0030758211     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199706000-00005     Document Type: Article

References (33)

1. The Rett Syndrome Diagnostic Criteria Work Group. Diagnostic criteria for Rett syndrome. Ann Neurol 1988; 23: 425-428.
2. Rett A. Über ein eigenartiges himatrophisches syndrom bei hyperammonàmie im kindesalter. Wien Med Wochenschr 1966; 116: 723-726.
3. Hagberg B. Rett syndrome: Swedish approach to analysis of prevalence and cause. Brain Dev 1985; 7: 277-279.
4. Kormann-Bortolotto MH, Woods CG, Green SH, Webb T. X-inactivation in girls with Rett syndrome. Clin Genet 1992; 42: 296-301.
5. Migeon BR, Dunn MA, Thomas G, Schmeckpeper BJ, Naidu S. Studies of X inactivation and isodisomy in twins provide further evidence that the X-chromosome is not involved in Rett syndrome. Am J Hum Genet 1995; 56: 647-653.
6. Hayek Y, Guama M. Antineuronal antibodies in Rett syndrome. Eur J Neurosci 1995; 8 (suppl.): 124.
7. Armstrong D. The neuropathology of Rett syndrome. Brain Dev 1992; 14: 89-94.
8. Oldfors A, Sourander P, Armstrong DL, Percy AK, Witt-Engerstrom I, Hagberg BA. Rett syndrome: Cerebellar pathology. Pediatr Neuro 1990; 6: 310-314.
9. Kaufmann WE, Hohmann CF, Israel, Naidu S. Micro-tubule-associated protein 2 is abnormally expressed in the neocortex of Rett syndrome subjects and in related animal model. Ann Neurol 1995; 38: 500.
10. Hagberg B, Skjeldal OH. Rett variants: A suggested model for inclusion criteria. Pediatr Neurol 1990; 47: 982-986.
11. Elian M, Rudolf N de M. EEG and respiration in Rett syndrome. Acta Neurol Scand 1991; 83: 123-128.
12. Nielsen JB, Friberg L, Lou H, Lassen NA, Sam ILK. Immature pattern of brain activity in Rett syndrome. Arch Neurol 1990; 47: 982-986.
13. Nielsen JB, Toft PB, Nielsen ER et al. Cerebral magnetic resonance spectroscopy in Rett syndrome. Brain Dev 1993; 15: 107-112.
14. Yoshikawa H, Fucki N, Suzuki H, Sakuragawa N, Ilio M. Cerebral blood flow and oxygen metabolism in the Rett syndrome. Brain Dev 1992; 14 (suppl.): S69-S74.
15. Reiss AL, Faruque F, Naidu S et al. Neuroanatomy of Rett syndrome: A volumetric imaging study. Ann Neurol 1993; 34: 227-234.
16. Knudsen GM, Andersen AR, Somnier FE, Videbaek C, Hasselbalch S, Paulson OB. Brain extraction and distribution of 99mTc-Bicisate in humans and rats. J Cereb Blood Flow Metab 1994; 14 (suppl. 1): S12-S18.
17. Friberg L, Andersen AR, Lassen NA, Holm S, Dam M. Retention of 99mTc-Bicisate in the human brain after intra-carotid injection. J Cereb Blood Flow Metab 1994; 14 (suppl. 1): S19-S27.
18. Pupi A, Castagnoli A, De Critofaro MTR, Baciottini L, Petti AR. Quantitative comparison between 99mTc-HMPAO and 99mTc-ECD: Measurement of arterial input and brain retention. Eur J Nucl Med 1994; 21: 124-130.
19. Garrett K, Villanueva J, Kuperus J, Giombetti R, Mena I. A comparison of regional cerebral blood flow with Xel33 to SPECT Tc99m-ECD. J Nucl Med 1988; 29: 913.
20. Vallbhajosula S, Zimmerman RE, Picard M et al. Technetium-99m ECD: A new tracer brain imaging agent. In vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med 1989; 30: 599-604.
21. Leveillfc J, Demonceau G, Walovitch RC. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med 1992; 33: 480-484.
22. Grunwald F, Menzel C, Pavis L et al. Ictal and interictal brain SPECT imaging in epilepsy using technethun-99m-ECD. J Nucl Med 1994; 35: 1896-1901.
23. Vattimo A, Burroni L, Bertelli P, Volterrani D, Vella A. Cerebral perfusion abnormalities in therapy-resistant epilepsy in childhood: Comparison between EEG, MRI and Tc99m-ECD brain SPET. Nucl Med Commun 19; 17: 48-53.
24. Hagberg B, Witt-Engerstom I. Rett syndrome: A suggested staging system for describing the impairment profile with increasing age towards adolescence. Am J Med Gen 1986; 24 (suppl.): 47-59.
25. Davis PC, Gray L, Albert M and the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part 11. Reliability of a standardized MR1 evaluation of Alzheimer’s disease. Neurology 1992; 42: 1676-1680.
26. Victoroff J, Mack WJ, Grafton ST, Schreiber SS, Chui HC. A method to improve interrater reliability of visual interpretation of brain MRI scans in dementia. Neurology 1994; 44: 2267-2276.
27. Krageloh-Mann I, Schroth G, Neimann G, Michaelis R. The Rett syndrome: Magnetic resonance imaging and clinical findings in four girls. Brain Dev 1989; 11: 175-178.
28. De Critofaro MTR, Sessarego A, Pupi A, Biondi F, Faravelli C. Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients. A SPECT study. Biol Psychiatry 1993; 33: 505-512.
29. Nellhaus G. Head circumference from birth to eighteen years. Pediatrics 1968; 41: 106-114.
30. Colamussi P, Giganti M, Cittanti C et al. Brain singlephoton emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: Relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med 1995; 22: 17-24.
31. Keymeulen B, de Metz K, Cluydts R, Bossuyt A, Somers G. Technetium-99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes. Eur J Nucl Med 1996; 23: 163-168.
32. Mountz JM, Tolbert LC, Lill DW, Katholi CR, Liu HG. Functional deficits in autistic disorder: Characterization by technetium-99m-HMPAO and SPECT. J Nucl Med 1995; 36: 1156-1162.
33. Vanhanen SL, Liewendahl K, Raininko R et al. Brain perfusion SPECT in infantile neuronal ceroid-lipofuscinosis (INCL): Comparison with clinical manifestations and MRI findings. Neuropediatrics 1996; 27: 76-83.